08/03
Headlines

NASDAQ:CLVS

Hot News: Clovis Oncology (NASDAQ:CLVS), Nokia Corporation (ADR) (NYSE:NOK), Key Technology (NASDAQ:KTEC), The First Bancorp (NASDAQ:FNLC), Capital One Financial (NYSE:COF)

Jayne Crisman02 mins

Leerink Swann initiated coverage on shares of Clovis Oncology (NASDAQ:CLVS) in a research report released on Friday morning. The firm issued an outperform rating and a $100.00 price objective on the stock. Clovis Oncology, Inc. (NASDAQ:CLVS) belongs to Healthcare sector. Its weekly performance is 11.49%. On last trading day company shares ended up $48.61. Clovis Oncology, Inc….

Read More

Stocks to Watch: Arch Coal Inc (NYSE:ACI), Clovis Oncology (NASDAQ:CLVS), 8×8 (NASDAQ:EGHT), Pier 1 Imports (NYSE:PIR), Jive Software Inc (NASDAQ:JIVE)

Kristen Barton03 mins

Arch Coal Inc. (NYSE:ACI) need to fix it all to protect shareholder value and its falling share prices. The Company won top Colorado awards during last month for its environmental friendly measures as well as workplace safety. However, the recent Environmental Protection Agency’s proposal to reduce carbon emission by cutting coal use and recent accusations…

Read More

Biotech Volatile Stocks: Aastrom Biosciences Inc (NASDAQ:ASTM), Puma Biotechnology Inc (NYSE:PBYI), Oncolytics Biotech (NASDAQ:ONCY), Clovis Oncology (NASDAQ:CLVS), Idenix Pharmaceuticals (NASDAQ:IDIX)

Richard Atkins03 mins

Aastrom Biosciences Inc (NASDAQ:ASTM) posted its quarterly earnings results on Thursday. The company reported ($1.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by $0.34, AnalystRatings.NET reports. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of the company in a research note on Friday, March…

Read More

Bearish Stocks at NASDAQ: Conatus Pharmaceuticals (NASDAQ:CNAT), Metabolix (NASDAQ:MBLX), Clovis Oncology (NASDAQ:CLVS), Oculus Innovative Sciences (NASDAQ:OCLS)

Richard Atkins02 mins

On March 27, 2014, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) issued a press release announcing its financial results for the quarter and year ended December 31, 2013. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) stock performance was -15.63% in last session and finished the day at $8.42. Traded volume was 1.28 million shares in the last session and the average…

Read More

Biotech Unusual Volume: Capstone Therapeutics (OTCMKTS:CAPS), Xencor (NASDAQ:XNCR), Durata Therapeutics (NASDAQ:DRTX), Clovis Oncology (NASDAQ:CLVS)

Kristen Barton02 mins

Capstone Therapeutics Corp. (OTCMKTS:CAPS) and its joint venture affiliate, LipimetiX Development, LLC (“JV”), today will hold a conference call and webcast to provide an operating update, discuss the start of AEM-28 Phase 1 clinical studies and report financial results for the fiscal year 2013. Capstone Therapeutics Corp. (OTCMKTS:CAPS) stock performance was 4.00% in last session…

Read More

NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)

Mark Doerr02 mins

Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014. The description of this program is set forth in Exhibit 99.1 and is incorporated herein by reference. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) dropped -6.61 percent to $26.01 Friday on volume…

Read More